Capture insights from a recent roundtable in which experts from across the biopharma industry shared their views on the recent rise in parenteral drug delivery development and what it means for both patients and the pharma industry.

You’ll access the key takeaways from this discussion, including:

• The factors driving increased demand for self-administered drugs and autoinjectors
• The pharma industry shift toward patient-centered development
• What wins out when balancing go-to-market time and risk
• Nurturing a “journey to confidence” for patients
• Realizing the value of connectivity in parenteral drug delivery devices